Jennifer M. Tharp

Jennifer has developed experience advising international and domestic clients in the automotive and engine manufacturing industries on mobile source regulations for the US Environmental Protection Agency (EPA) and the California Air Resources Board (CARB). This has included review of certification documentation, development of legal strategy, and participation as counsel to the Monitor for a government investigation.

Jennifer also works with the Life Sciences Industry Group and advises clients on a variety of Food and Drug Administration (FDA) regulatory matters. In particular, she has assisted clients with labeling questions relating to food and dietary supplements. More recently, she has guided clients on FDA matters relating to coronavirus disease 2019 (COVID-19), such as emergency use authorizations for medical devices, and drafted company response plans.

Jennifer previously completed a summer internship with a private research university during law school, and her projects included regulatory analysis for counsel of both the university and health system. She also worked as a research assistant for a nonprofit operating federally funded research and development centers on tasks including policy analysis and compliance.

Jennifer has been published in Lexology, Law360 and the Journal of Legal Medicine. She is also an active board member of Playhouse Square Partners in Cleveland, Ohio, a member of the Association of Women in the Metals Industry (AWMI) and a member of the Food and Drug Law Institute (FDLI).